Medivolve Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was CAD 0.182625 million compared to CAD 0.317758 million a year ago. Net loss was CAD 3.51 million compared to CAD 6.97 million a year ago. Basic loss per share from continuing operations was CAD 0.04 compared to CAD 0.08 a year ago. Diluted loss per share from continuing operations was CAD 0.04.
For the nine months, sales was CAD 0.430439 million compared to CAD 1.02 million a year ago. Net loss was CAD 8.08 million compared to CAD 14.38 million a year ago.